Experimental and clinical approaches for optimization of the graft-versus-leukemia effect - PubMed (original) (raw)
Review
Experimental and clinical approaches for optimization of the graft-versus-leukemia effect
Ben Sprangers et al. Nat Clin Pract Oncol. 2007 Jul.
Abstract
The goal of allogeneic (allo)-hematopoietic stem-cell transplantation (HSCT) in the treatment of hematologic malignancies is to harness the graft-versus-leukemia (GVL) effect, while minimizing the risk of graft-versus-host disease (GVHD). Allo-HSCT research has focused on the GVL target antigens and effector mechanisms, and on potential approaches to exploit GVL independently of GVHD. Donor lymphocyte infusion (DLI) achieves the most powerful anti-leukemic responses, and this approach is often used in combination with nonmyeloablative transplant regimens to optimize GVL and reduce GVHD. Serial, dose-escalating, and CD8(+) T-cell-depleted DLI have been introduced into clinical practice, while other variants of DLI have so far been explored only in animal models. The role of naturally occurring regulatory T cells in transplantation tolerance is being increasingly acknowledged, and murine studies indicate the potential ability of T cells to regulate GVHD while maintaining GVL. Experimental and clinical studies have demonstrated the importance of host-type chimerism, particularly for antigen-presenting cells, in determining the occurrence of DLI-induced GVL. Murine studies could assist in the development of clinical strategies targeted at antigen-presenting cells. Clinical studies exploiting natural killer-cell-mediated antitumor reactivity in the context of killer inhibitory receptor-ligand-mismatched allo-HSCT have provided promising results.
Similar articles
- Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G, Wu D, Wang Y, Cen J, Feng Y, Sun A, Tang X, Chang H, Zhu Z. Chen G, et al. Eur J Haematol. 2008 Sep;81(3):226-35. doi: 10.1111/j.1600-0609.2008.01108.x. Epub 2008 Jun 28. Eur J Haematol. 2008. PMID: 18573173 - Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE. Talmadge JE. Int Immunopharmacol. 2003 Aug;3(8):1121-43. doi: 10.1016/S1567-5769(03)00014-6. Int Immunopharmacol. 2003. PMID: 12860168 Review.
Cited by
- Transitory Spontaneous Remission of Myelodysplasia in an Elderly Man while Receiving Intravesical Bacillus Calmette-Guérin for Bladder Cancer: A Case Report and Review of the Literature.
Murray NP, Fuentealba C, Salazar I, Salazar A, Lopez MA, Minzer S. Murray NP, et al. Case Rep Hematol. 2018 Nov 11;2018:9750532. doi: 10.1155/2018/9750532. eCollection 2018. Case Rep Hematol. 2018. PMID: 30534450 Free PMC article. - Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patients.
Gozdzik J, Rewucka K, Krasowska-Kwiecien A, Pieczonka A, Debski R, Zaucha-Prazmo A, Drabko K, Krukowska-Jaros J, Wozniak M, Kowalczyk J, Wysocki M, Gorczynska E, Kalwak K, Chybicka A, Wachowiak J. Gozdzik J, et al. Bone Marrow Transplant. 2015 Jan;50(1):51-5. doi: 10.1038/bmt.2014.200. Epub 2014 Oct 13. Bone Marrow Transplant. 2015. PMID: 25310307 - Recipient leukocyte infusion enhances the local and systemic graft-versus-neuroblastoma effect of allogeneic bone marrow transplantation in mice.
Willems L, Fevery S, Sprangers B, Rutgeerts O, Lenaerts C, Ibrahimi A, Gijsbers R, Van Gool S, Waer M, Billiau AD. Willems L, et al. Cancer Immunol Immunother. 2013 Nov;62(11):1733-44. doi: 10.1007/s00262-013-1479-6. Epub 2013 Oct 1. Cancer Immunol Immunother. 2013. PMID: 24081484 Free PMC article. - The cancer antigenome.
Heemskerk B, Kvistborg P, Schumacher TN. Heemskerk B, et al. EMBO J. 2013 Jan 23;32(2):194-203. doi: 10.1038/emboj.2012.333. Epub 2012 Dec 21. EMBO J. 2013. PMID: 23258224 Free PMC article. Review. - Visualization of immune response kinetics in full allogeneic chimeras.
Elkin G, Prigozhina TB, Slavin S, Gurevitch O, Khitrin S, Resnick IB. Elkin G, et al. Am J Blood Res. 2011;1(2):110-8. Epub 2011 Aug 22. Am J Blood Res. 2011. PMID: 22432073 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials